KR860700254A - 메틸렌-비스포스폰산 유도체의 제조방법 - Google Patents

메틸렌-비스포스폰산 유도체의 제조방법

Info

Publication number
KR860700254A
KR860700254A KR1019860700180A KR860700180A KR860700254A KR 860700254 A KR860700254 A KR 860700254A KR 1019860700180 A KR1019860700180 A KR 1019860700180A KR 860700180 A KR860700180 A KR 860700180A KR 860700254 A KR860700254 A KR 860700254A
Authority
KR
South Korea
Prior art keywords
methyl
alkyl
carbon atoms
ester
hydrogen
Prior art date
Application number
KR1019860700180A
Other languages
English (en)
Inventor
토른달 빈데루프 에른스트
Original Assignee
원본미기재
레오 파머슈티컬 프로덕츠 리미티드 에이/에스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 레오 파머슈티컬 프로덕츠 리미티드 에이/에스 filed Critical 원본미기재
Publication of KR860700254A publication Critical patent/KR860700254A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/386Polyphosphonic acids containing hydroxy substituents in the hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

내용 없음

Description

메틸렌-비스포스폰산 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 일반식(Ⅱ)의 디클로로메틸 에테르를 출발물질로 사용하고, 하기 반응순서를 따라서 일반식(Ⅰ)의 화합물 및 약제학적으로 허용되는 비독성 염과 신체에서 쉽게 가수분해되는 그의 에스테르를 제조하는 방법.
    [반응순서]
    상기 식에서,
    R1은 직쇄 또는 측쇄, 포화 또는 불포화 지방족 또는 지환식 C1-C10탄화수소기, 아릴 또는 아릴-C1-C4-알킬기이고, 경우에 따라 R1은 직쇄 또는 측쇄 C1-C4-알킬, 아미노, C1-C4-알킬아미노, 디-(C1-C4-알킬)-아미노, 카복시, C1-C4-알콕시카보닐, 하이드록시, C1-C4-알콕시, 페녹시, 머캅토, C1-C4-알킬티오, 페닐티오, 할로겐, 트리플루오로메틸로 치환 또는 비치환되며: R2는 수소, C1-C8-알킬, 아릴-C1-C4-알킬 또는 할로겐을 나타내고: X는 산소 또는 황이며, n은 0 내지 2의 정수이나: 단 n=0이고 R1이 메틸인 경우 R2가 수소 또는 메틸이 될 수 없으며, n=0이고 R1이 비치환된 n-부틸, n-펜틸 또는 n-헥실인 경우 R2가 수소가 될수는 없다.
  2. 제1항에 있어서, R1이 아미노, 하이드록시, 메틸 또는 할로겐으로 임의 치환된 직쇄 또는 측쇄 C3-C6알킬, 페닐 또는 벤질을 나타내고, R2가 수소, 직쇄 또는 측쇄 C1-C4-알킬, 벤질 또는 할로겐을 나타내며: 바람직하게는 R1이 프로필, 부틸, 아미노프로필, 아미노부틸, 2,2,2-트리플루오로에틸, 페닐 또는 톨릴이고, R2가 수소, 메틸 에틸 또는 염소인 방법.
  3. 제1항에 있어서, 알칼리 금속염, 알킬리성 토금속염, 암모니아와의 염, 저급 알킬아민, 저급 알카노일아민, 프로카인, 사이클로알킬아민, 벤질아민, 및 헤테로환식 아민으로 이루어진 그룹으로부터 선택한 염인, 일반식(Ⅰ)화합물의 1-, 2-, 3- 또는 4염기성 염인 방법.
  4. 제1항에 있어서, 생체내에서 쉽게 가수분해되는 에스테르로, 에스테르 형성 잔기는 탄소수 3 내지 6인 알카노일옥시메틸, 탄소수 4 내지 7인 1-(알카노일옥시)에틸, 탄소수 5 내지 8인 1-메틸-1-(알카노일옥시)에틸, 탄소수 3 내지 6인 알콕시카보닐옥시메틸, 탄소수 4 내지 7인 1-(알콕시보닐카옥시)에틸, 탄소수 5 내지 8인 1-메틸-1-(알콕시카보닐옥시)에틸, 3-프탈리딜, 4-크로토놀락토닐, γ-부티롤락톤-4-일, (2-옥소-1,3-디옥솔렌-4-일)메틸, (5-메틸-2-옥소-1,3-디옥솔렌-4-일)메틸, 및 (5-페닐-2-옥소-1,3-디옥솔렌-4-일)메틸, 뿐만 아니라 디알킬아미노알킬, 아세토닐, 및 메톡시메틸로 이루어진 그룹중에서 선택한, 일반식(Ⅰ)화합물의 모노-, 디-, 트리- 또는 테트라 에스테르인 방법.
  5. 제4항에 있어서, 알카노일옥시알킬 또는 알콕시카보닐옥시 알킬 에스테르, 특히 피발로일옥시메틸 또는 에톡시카보닐옥시에틸 에스테르인 방법.
    ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019860700180A 1984-07-31 1985-07-25 메틸렌-비스포스폰산 유도체의 제조방법 KR860700254A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8419489 1984-07-31
GB848419489A GB8419489D0 (en) 1984-07-31 1984-07-31 Chemical compounds
PCT/DK1985/000071 WO1986000902A1 (en) 1984-07-31 1985-07-25 Derivatives of methylene-bisphosphonic acid, process for their preparation and a pharmaceutical composition

Publications (1)

Publication Number Publication Date
KR860700254A true KR860700254A (ko) 1986-08-01

Family

ID=10564711

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860700180A KR860700254A (ko) 1984-07-31 1985-07-25 메틸렌-비스포스폰산 유도체의 제조방법

Country Status (15)

Country Link
US (1) US4732998A (ko)
EP (1) EP0191044B1 (ko)
JP (1) JPH068303B2 (ko)
KR (1) KR860700254A (ko)
AU (1) AU583848B2 (ko)
DE (1) DE3575929D1 (ko)
DK (1) DK167808B1 (ko)
ES (1) ES8707964A1 (ko)
FI (1) FI861357A0 (ko)
GB (1) GB8419489D0 (ko)
GR (1) GR851865B (ko)
IE (1) IE58614B1 (ko)
PT (1) PT80886B (ko)
WO (1) WO1986000902A1 (ko)
ZA (1) ZA855264B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3805663A1 (de) * 1988-02-24 1989-09-07 Henkel Kgaa Oxaalkanpolyphosphonsaeuren, ihre verwendung als thresholder sowie diese verbindungen enthaltende, komplexierend wirkende zusammensetzungen
DE3822650A1 (de) * 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US5266722A (en) * 1988-11-09 1993-11-30 W. R. Grace & Co.-Conn. Polyether bis-phosphonic acid compounds
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
FI83421C (fi) * 1989-06-21 1991-07-10 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt anvaendbara metylenbisfosfonsyraderivat.
DE69023844T2 (de) * 1989-09-06 1996-06-20 Merck & Co Inc Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren.
US5227506A (en) * 1989-09-06 1993-07-13 Merck & Co., Inc. Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors
GB9024345D0 (en) * 1990-11-08 1990-12-19 Merck Sharp & Dohme Therapeutic agents
JP3141053B2 (ja) * 1991-12-26 2001-03-05 アベンティス ファーマ株式会社 ビスホスホン酸誘導体
US5200554A (en) * 1992-01-21 1993-04-06 Nasman Jan Anders H Bisphosphonic acid derivatives and their use
KR100272907B1 (ko) * 1992-07-10 2001-03-02 히라이 가쯔히꼬 메탄디포스폰산 유도체, 이의 제조방법 및 이의 의약 용도
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
US6143919A (en) * 1999-05-18 2000-11-07 3M Innovative Properties Company Polymerizable acidic compounds and methods of preparation
US6315566B1 (en) 1999-05-18 2001-11-13 3M Innovative Properties Company Dental materials
AU2002337862A1 (en) * 2001-10-18 2003-04-28 Ilex Products, Inc. Methods of treating skin with diphosphonate derivatives
DE102004032781A1 (de) * 2004-01-23 2005-08-11 Mcs Micro Carrier Systems Gmbh Bisphosphonsäurederivate
JP2006028024A (ja) * 2004-07-12 2006-02-02 Toray Ind Inc リン含有有機化合物の製造方法。
EP2289900A1 (en) * 2009-08-26 2011-03-02 Humboldt Universität zu Berlin Bisphosphonates as inhibitors of acid sphingomyelinase
CN104822695B (zh) * 2012-07-05 2018-01-09 衣阿华大学研究基金会 治疗性双膦酸盐
US10557039B2 (en) * 2016-02-22 2020-02-11 Surfactis Technologies Compositions comprising bisphosphonic compounds dissolved in a fluorinated solvent, and use thereof for covering the surface of a part

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA777769A (en) * 1963-03-18 1968-02-06 H. Roy Clarence Substituted methylene diphosphonic acid compounds and detergent compositions
US3400131A (en) * 1964-03-05 1968-09-03 Hoffmann La Roche 1, 3-di (4-pyridyl)-2-propanol derivatives
GB1115044A (en) * 1964-08-06 1968-05-22 Albright & Wilson Mfg Ltd Derivatives of hydroxy diphosphonic acids
AT279051B (de) * 1966-12-29 1970-02-25 Procter & Gamble Mundpflegemittel
US3400151A (en) * 1967-12-28 1968-09-03 Procter & Gamble Bicyclic dimer of ethane-1-hydroxy-1, 1-diphosphonic acid and salts thereof
US4014959A (en) * 1975-04-24 1977-03-29 Monsanto Company Phosphonoether carboxylates
SU772152A1 (ru) * 1977-07-20 1983-02-15 Центральный научно-исследовательский институт оловянной промышленности 1-Алкоксиалкилиден-1,1-дифосфоновые кислоты или их калиевые,натриевые или аммониевые соли в качестве собирателей дл флотации касситерита и способ их получени
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
IE851717L (en) 1986-01-31
ZA855264B (en) 1986-03-26
PT80886A (en) 1985-08-01
US4732998A (en) 1988-03-22
JPH068303B2 (ja) 1994-02-02
PT80886B (pt) 1987-11-30
GB8419489D0 (en) 1984-09-05
WO1986000902A1 (en) 1986-02-13
EP0191044B1 (en) 1990-02-07
IE58614B1 (en) 1993-10-20
GR851865B (ko) 1985-12-02
FI861357A (fi) 1986-03-27
JPS61503034A (ja) 1986-12-25
EP0191044A1 (en) 1986-08-20
ES545783A0 (es) 1987-09-01
DE3575929D1 (de) 1990-03-15
FI861357A0 (fi) 1986-03-27
AU583848B2 (en) 1989-05-11
DK147386D0 (da) 1986-04-01
AU4673685A (en) 1986-02-25
ES8707964A1 (es) 1987-09-01
DK167808B1 (da) 1993-12-20
DK147386A (da) 1986-04-01

Similar Documents

Publication Publication Date Title
KR860700254A (ko) 메틸렌-비스포스폰산 유도체의 제조방법
KR850006938A (ko) 폴루로뮤티린 유도체의 제조방법
KR930017898A (ko) 술포닐벤질 치환 피리돈
KR880012526A (ko) l-페닐-3-나프탈레닐옥시프로판아민
KR830006198A (ko) 시클로헥산 유도체의 제조방법
KR840004113A (ko) 7-아실아미노-3-세펨-4- 카르복실산 유도체의 제조방법
KR930023364A (ko) 비페닐메틸-치환 피리돈
ATE37872T1 (de) Phenylinden-derivate, ihre salze, und verfahren zu ihrer herstellung.
KR870003107A (ko) 키산틴 유도체의 제조방법
KR840001581A (ko) 베타-락타마제 억제제 2-베타-치환-2-알파-메틸-(5r)펜임-3-알파카복실산 1,1-디옥사이드 및 그 중간체의 제조방법
KR950003299A (ko) 세팔로스포린 합성 중간체
KR840000493A (ko) 피리딘으로부터 유도된 아미드 및 에스테르기를 포함하는 제초제의 제조방법
GB1496692A (en) Process for the preparation of ceph-2-em compounds
KR850004470A (ko) 유기 화합물의 제조방법
KR840006238A (ko) 신규 α-아릴-α-피리딜알카노인산 유도체의 제조방법
KR840005455A (ko) 세팔로스포린 유도체류의 제조방법
KR840000530A (ko) 신규 벤조트리아졸의 제조방법
KR850002979A (ko) 1,2,3-트리티안화합물의 신규 제조방법
KR840004747A (ko) 강심제 퀸아졸린의 제조방법
RU2004134319A (ru) Применение солей жирных аминов в комбинации с жирными кислотами в качестве вспомогательного средства для флотации калийных солей (сильвинита)
KR900011777A (ko) 신규한 아미노 카르복실산 유도체
KR860002451A (ko) 아미드 화합물의 제조방법
KR840009110A (ko) 알파-아미노 벤질 페니실린의 에스테르 화합물의 제조방법
KR900701744A (ko) 담색의 α-술포지방산 알킬 에스테르염의 제조방법
KR830005189A (ko) 에폭시석신산 유도체의 제조방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid